Results 21 to 30 of about 165,798 (191)

Efficacy and Safety Profile of Tuberculin Protein Purified Derivative Injection As Immunotherapy For the Treatment of Cutaneous and Anogenital Warts: A Review Article

ImmunoTargets and Therapy
Pati Aji Achdiat,1,2 Oki Suwarsa,1,2 Yudi Mulyana Hidayat,2,3 Mohamad Nasir Shafiee,4 Reiva Farah Dwiyana,1,2 Reti Hindritiani,1 Endang Sutedja,1 Satiti Retno Pudjiati,5 Dany Hilmanto,2,6 Meita Dhamayanti,2,6 Ida Parwati,2,7 Retno Hesty Maharani,1 Eva ...
Meita Dhamayanti, Eva Krishna Sutedja, Pati Aji Achdiat   +2 more
exaly   +2 more sources

Candida Antigen Immunotherapy for Treatment of Cutaneous Warts: A one-Year Zagazig University-Dermatology Clinic Experience. [PDF]

Zagazig University Medical Journal, 2021
Background: Warts are widespread cutaneous and mucosal infections caused by human papilloma virus. Resistance to treatment is the main concern while dealing with cutaneous warts. Previous research has defined an ideal wart therapeutic modality as the one
Amany Nassar, Ayman Marei, Mohamed Nasr, Mona Imam   +3 more
doaj   +1 more source

Evaluation of serum selenium levels in patients with multiple warts: a case–control study in the north of Iran

Journal of the Egyptian Women’s Dermatologic Society, 2022
Background Some micronutrients including selenium (Se) have immunoregulatory effects in the body. Our hypothesis was that decreased serum Se levels could be associated with some degree of immunodeficiency and increased chance of multiple cutaneous warts.
Narges Alizadeh, Rana Rafiei, Abbas Darjani, Hojat Eftekhari, Kaveh Gharaei Nejad, Elahe Rafiei, Meghdad Nasiri   +6 more
doaj   +1 more source

Systematic Review of Intralesional Therapies for Cutaneous Warts [PDF]

JID Innovations
Jenna Mueller, Melodi Javid Whitley, Emma Myers   +2 more
exaly   +2 more sources

Efficacy and Safety of Intralesional Immunotherapy with Tuberculin Purified Protein Derivative among Cutaneous Wart Patients

Journal of Nepal Health Research Council, 2023
Background: Cutaneous warts are common skin problems caused by Human Papilloma Virus. Conventional therapies are mostly ablative and limited by recurrences and side effects.
Sanju Babu Shrestha, Mohan Bhusal, Jayanti Jwarchan, Sujan Gautam, Prashanna Raj Shrestha   +4 more
doaj   +1 more source

The Role of Intralesional Vitamin D3 injection in Treatment of Cutaneous Warts [PDF]

المجلة العراقية للصيدلة, 2022
Background: Cutaneous warts are treated primarily with destructive methods such as cryotherapy or electro-cautery. These modalities of treatment are time‑consuming and may be associated with scarring in multiple warts.
Fenk Ali, Sangar Jalal
doaj   +1 more source

Intralesional cidofovir for the management of refractory cutaneous verrucae: a review of applications and opportunities

Therapeutic Advances in Infectious Disease, 2023
Viral warts – manifestations of cutaneous infection by human papilloma virus – can be a significant physical and emotional burden for patients when common treatments fail, particularly for individuals who are immunocompromised or with multiple lesions ...
William C. Lau, Charles B. Lau, Jason E. Frangos, Vinod E. Nambudiri   +3 more
doaj   +1 more source

Efficacy and Safety of Microneedling for the Treatment of Cutaneous Warts. [PDF]

Hand (N Y), 2019
De Vita V, Goldust M.
europepmc   +4 more sources

The seroepidemiology of human-papillomavirus in relation to non-melanoma skin cancer [PDF]

, 2009
PhDNon-melanoma skin cancer, comprising basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) is the most commonly diagnosed cancer in Caucasian populations.
Casabonne, Delphine
core   +4 more sources

Topical Imiquimod 5% Cream Versus Salicylic acid 30% Cream in Treating Common Warts: A comparative study [PDF]

المجلة العراقية للصيدلة, 2022
Background: Warts are considered the foremost common infectious diseases affecting the epidermal keratinocytes, the causative agent is the human papilloma virus (HPV).
Dilpak Muhammed-Ameen, Alan Meran
doaj   +1 more source